Patient considerations in the management of ulcerative colitis – role of vedolizumab

Ulcerative colitis (UC) is a subtype of inflammatory bowel disease which causes inflammation of the large intestine and affects approximately 7.6–24.6 per 100,000 persons. The therapeutic goal for UC patients is inducing remission, maintaining remission, and ideally, obtaining mucosal healing. Vedol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothari, Megha, Mudireddy, Prashant, Swaminath, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548764/
https://www.ncbi.nlm.nih.gov/pubmed/26316768
http://dx.doi.org/10.2147/TCRM.S65650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548764/
https://www.ncbi.nlm.nih.gov/pubmed/26316768
http://dx.doi.org/10.2147/TCRM.S65650

Ejemplares similares